| Anthony Mattioda, | |
|
1350 N 1st St, Hermiston, OR 97838-1102 | |
| (541) 567-5323 | |
| Not Available |
| Full Name | Anthony Mattioda |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1350 N 1st St, Hermiston, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285259648 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RPH-0017683 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Anthony Mattioda, 26350 Horsell Rd, Bend, OR 97701-9688 Ph: (541) 306-0683 | Anthony Mattioda, 1350 N 1st St, Hermiston, OR 97838-1102 Ph: (541) 567-5323 |
News Archive
The higher the percentage of people in a city, town or neighborhood with Facebook interests suggesting a healthy, active lifestyle, the lower that area's obesity rate.
The multi-disciplinary research, the first of its kind to examine judges' perceptions of child witnesses, was led by Queen's Child and Family Law scholar Nick Bala. It addresses how judges assess the honesty and reliability of children's court testimony, and how accurate their observations are.
Johnson & Johnson Pharmaceutical Research and Development, L.L.C. (J&JPRD), announced today that results from the Phase III EINSTEIN-Extension (EXT) clinical trial of the novel oral anticoagulant rivaroxaban showed a significant reduction in the risk of recurrent symptomatic venous thromboembolism (VTE), compared to placebo, in patients who have been treated for a previous deep vein thrombosis (DVT) or pulmonary embolism (PE).
A quartet of studies by researchers at the California Institute of Technology (Caltech) highlight a special feature on gene regulatory networks recently published in the Proceedings of the National Academy of Sciences ( PNAS ).
A large international study led by University of Melbourne researchers has identified a mutation linked to breast cancer attached to the newly identified gene, called XRCC2. Lead researcher Melissa Southey said the discovery, using high-speed technology, would hopefully mean that more gene mutations responsible for causing breast cancer could be rapidly identified in the next few years.
› Verified 5 days ago
Christopher James Eden, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 610 Nw 11th St, Hermiston, OR 97838 Phone: 541-667-3400 | |
David Turnbull, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 835 S Highway 395, Hermiston, OR 97838 Phone: 541-567-7805 | |
Jeremy Wagner, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 990 S Highway 395, Hermiston, OR 97838 Phone: 541-564-1285 | |
Mayra L Barrera, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 589 Nw 11th St, Hermiston, OR 97838 Phone: 541-567-1717 | |
Jeff Kendrick, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 610 Nw 11th St, Hermiston, OR 97838 Phone: 541-667-3647 Fax: 541-667-3454 | |
Mr. Manu John Jose, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 835 S Highway 395, Hermiston, OR 97838 Phone: 541-567-7805 | |
William Burke, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 610 Nw 11th St, Hermiston, OR 97838 Phone: 541-667-3647 Fax: 541-667-3454 |